2021 Q4 Form 10-Q Financial Statement
#000147793222000262 Filed on January 14, 2022
Income Statement
Concept | 2021 Q4 | 2020 Q4 |
---|
Balance Sheet
Concept | 2021 Q4 | 2020 Q4 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $34.85K | $80.91K |
YoY Change | -56.93% | 75.05% |
Cash & Equivalents | $34.85K | |
Short-Term Investments | ||
Other Short-Term Assets | $10.00K | $155.4K |
YoY Change | -93.56% | 3007.6% |
Inventory | $176.0K | $291.9K |
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $220.8K | $528.2K |
YoY Change | -58.2% | 47.68% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $5.495M | $4.914M |
YoY Change | 11.81% | 3.55% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $5.520M | $4.914M |
YoY Change | 12.32% | 3.55% |
TOTAL ASSETS | ||
Total Short-Term Assets | $220.8K | $528.2K |
Total Long-Term Assets | $5.520M | $4.914M |
Total Assets | $5.741M | $5.443M |
YoY Change | 5.48% | 6.64% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $648.6K | $333.3K |
YoY Change | 94.6% | 182.88% |
Accrued Expenses | $64.94K | $40.78K |
YoY Change | 59.24% | 57.63% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | -100.0% | |
Long-Term Debt Due | $3.562M | $514.5K |
YoY Change | 592.29% | |
Total Short-Term Liabilities | $8.549M | $5.373M |
YoY Change | 59.11% | 167.92% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $4.560M | $4.607M |
YoY Change | -1.02% | -1.84% |
Other Long-Term Liabilities | $0.00 | |
YoY Change | ||
Total Long-Term Liabilities | $4.560M | $4.607M |
YoY Change | -1.02% | -1.84% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $8.549M | $5.373M |
Total Long-Term Liabilities | $4.560M | $4.607M |
Total Liabilities | $13.11M | $9.980M |
YoY Change | 31.35% | 48.99% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$59.49M | |
YoY Change | ||
Common Stock | $44.48K | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$7.368M | -$4.537M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $5.741M | $5.443M |
YoY Change | 5.48% | 6.64% |
Cashflow Statement
Concept | 2021 Q4 | 2020 Q4 |
---|
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q4 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2021Q4 | dei |
Document Type
DocumentType
|
10-Q | |
CY2021Q4 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2021Q4 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-10-31 | |
CY2021Q4 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2021Q4 | dei |
Entity File Number
EntityFileNumber
|
000-54338 | |
CY2021Q4 | dei |
Entity Registrant Name
EntityRegistrantName
|
GREEN HYGIENICS HOLDINGS INC. | |
CY2021Q4 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2021Q4 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
26-2801338 | |
CY2021Q4 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
13795 Blaisdell Place | |
CY2021Q4 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 202 | |
CY2021Q4 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Poway | |
CY2021Q4 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | |
CY2021Q4 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
92064 | |
CY2021Q4 | dei |
City Area Code
CityAreaCode
|
1-855 | |
CY2021Q4 | dei |
Local Phone Number
LocalPhoneNumber
|
802-0299 | |
CY2021Q4 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2021Q4 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2021Q4 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2021Q4 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2021Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
44482138 | shares |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
34847 | USD |
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
507512 | USD |
CY2021Q4 | us-gaap |
Deposits Assets
DepositsAssets
|
10000 | USD |
CY2021Q3 | us-gaap |
Deposits Assets
DepositsAssets
|
0 | USD |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
175957 | USD |
CY2021Q3 | us-gaap |
Inventory Net
InventoryNet
|
0 | USD |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
220804 | USD |
CY2021Q3 | us-gaap |
Assets Current
AssetsCurrent
|
507512 | USD |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5494912 | USD |
CY2021Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5522326 | USD |
CY2021Q4 | us-gaap |
Intangible Assets Current
IntangibleAssetsCurrent
|
25000 | USD |
CY2021Q3 | us-gaap |
Intangible Assets Current
IntangibleAssetsCurrent
|
25000 | USD |
CY2021Q4 | us-gaap |
Assets
Assets
|
5740716 | USD |
CY2021Q3 | us-gaap |
Assets
Assets
|
6054838 | USD |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
396160 | USD |
CY2021Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
749592 | USD |
CY2021Q4 | us-gaap |
Servicing Liability
ServicingLiability
|
403503 | USD |
CY2021Q3 | us-gaap |
Servicing Liability
ServicingLiability
|
304383 | USD |
CY2021Q4 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
648638 | USD |
CY2021Q3 | gryn |
Mortgage Payable
MortgagePayable
|
2750000 | USD |
CY2021Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
1760000 | USD |
CY2021Q3 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
1760000 | USD |
CY2021Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
4559694 | USD |
CY2021Q3 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
523791 | USD |
CY2021Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
4575591 | USD |
CY2021Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
64937 | USD |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
13108690 | USD |
CY2021Q3 | us-gaap |
Liabilities
Liabilities
|
12898367 | USD |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
375000000 | shares |
CY2021Q3 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
58953 | USD |
CY2021Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
3562038 | USD |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
44482138 | shares |
CY2021Q3 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
3557594 | USD |
CY2021Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
44126138 | shares |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
44482 | USD |
CY2021Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
44126 | USD |
CY2021Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
3473720 | USD |
CY2021Q4 | gryn |
Stock Payable
StockPayable
|
100000 | USD |
CY2020Q4 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
40956924 | shares |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6843529 | USD |
CY2021Q3 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
3128463 | USD |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
8548996 | USD |
CY2021Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
8322776 | USD |
CY2021Q4 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
49694 | USD |
CY2021Q3 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
65891 | USD |
CY2021Q4 | gryn |
Mortgage Payable
MortgagePayable
|
2750000 | USD |
CY2021Q3 | gryn |
Stock Payable
StockPayable
|
812000 | USD |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
51977994 | USD |
CY2021Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
51186075 | USD |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-59490450 | USD |
CY2021Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-58885730 | USD |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-7367974 | USD |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6843529 | USD |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5740716 | USD |
CY2021Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
6054838 | USD |
CY2021Q4 | us-gaap |
Revenues
Revenues
|
4500 | USD |
CY2020Q4 | us-gaap |
Revenues
Revenues
|
40954 | USD |
CY2021Q4 | us-gaap |
Business Development
BusinessDevelopment
|
154655 | USD |
CY2020Q4 | us-gaap |
Business Development
BusinessDevelopment
|
85991 | USD |
CY2021Q4 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
0 | USD |
CY2020Q4 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1904950 | USD |
CY2021Q4 | us-gaap |
Other Labor Related Expenses
OtherLaborRelatedExpenses
|
157500 | USD |
CY2020Q4 | us-gaap |
Other Labor Related Expenses
OtherLaborRelatedExpenses
|
52500 | USD |
CY2021Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
179828 | USD |
CY2020Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
231048 | USD |
CY2021Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
491983 | USD |
CY2020Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
2279235 | USD |
CY2021Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-487483 | USD |
CY2020Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2238281 | USD |
CY2021Q4 | us-gaap |
Interest Expense
InterestExpense
|
297237 | USD |
CY2020Q4 | us-gaap |
Interest Expense
InterestExpense
|
191440 | USD |
CY2021Q4 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
180000 | USD |
CY2020Q4 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | USD |
CY2021Q4 | gryn |
Other Income And Expenses
OtherIncomeAndExpenses
|
-117237 | USD |
CY2020Q4 | gryn |
Other Income And Expenses
OtherIncomeAndExpenses
|
-191440 | USD |
CY2021Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-604720 | USD |
CY2020Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2429721 | USD |
CY2021Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
CY2020Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.06 | |
CY2021Q4 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
44482138 | shares |
CY2020Q4 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
1904050 | USD |
CY2021Q4 | gryn |
Imputed Interest
ImputedInterest
|
80275 | USD |
CY2021Q4 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
0 | USD |
CY2021Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-604720 | USD |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-7367974 | USD |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4432520 | USD |
CY2020Q4 | gryn |
Imputed Interest
ImputedInterest
|
76778 | USD |
CY2020Q4 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
1904050 | USD |
CY2020Q4 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
155383 | USD |
CY2020Q4 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
188700 | USD |
CY2020Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2429721 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4537330 | USD |
CY2021Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-604720 | USD |
CY2020Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2429721 | USD |
CY2021Q4 | gryn |
Imputed Interest
ImputedInterest
|
80275 | USD |
CY2020Q4 | gryn |
Imputed Interest
ImputedInterest
|
76778 | USD |
CY2021Q4 | us-gaap |
Depreciation
Depreciation
|
62439 | USD |
CY2020Q4 | us-gaap |
Depreciation
Depreciation
|
30177 | USD |
CY2021Q4 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
0 | USD |
CY2021Q4 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
0 | USD |
CY2020Q4 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
716 | USD |
CY2021Q4 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
CY2020Q4 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
1500 | USD |
CY2021Q4 | gryn |
Foreign Currency Losses
ForeignCurrencyLosses
|
1321 | USD |
CY2020Q4 | gryn |
Foreign Currency Losses
ForeignCurrencyLosses
|
0 | USD |
CY2021Q4 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
4444 | USD |
CY2020Q4 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | USD |
CY2021Q4 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-10000 | USD |
CY2020Q4 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
0 | USD |
CY2021Q4 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-175957 | USD |
CY2020Q4 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-291928 | USD |
CY2021Q4 | us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
5984 | USD |
CY2020Q4 | us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
-117639 | USD |
CY2021Q4 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-254312 | USD |
CY2020Q4 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
119609 | USD |
CY2021Q4 | us-gaap |
Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
|
124847 | USD |
CY2020Q4 | us-gaap |
Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
|
27500 | USD |
CY2021Q4 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
0 | USD |
CY2020Q4 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-15973 | USD |
CY2021Q4 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-765679 | USD |
CY2020Q4 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-694931 | USD |
CY2021Q4 | us-gaap |
Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
|
35025 | USD |
CY2020Q4 | us-gaap |
Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
|
29833 | USD |
CY2021Q4 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-35025 | USD |
CY2020Q4 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-29833 | USD |
CY2021Q4 | gryn |
Shares Issued For Prepaid Expenses
SharesIssuedForPrepaidExpenses
|
0 | USD |
CY2020Q4 | gryn |
Payments On Discounted Note Payable
PaymentsOnDiscountedNotePayable
|
171213 | USD |
CY2021Q4 | gryn |
Payments On Related Parties Loans
PaymentsOnRelatedPartiesLoans
|
77913 | USD |
CY2020Q4 | gryn |
Payments On Related Parties Loans
PaymentsOnRelatedPartiesLoans
|
70000 | USD |
CY2021Q4 | gryn |
Principle Payments On Notes Payable
PrinciplePaymentsOnNotesPayable
|
15897 | USD |
CY2020Q4 | gryn |
Principle Payments On Notes Payable
PrinciplePaymentsOnNotesPayable
|
7149 | USD |
CY2021Q4 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
421849 | USD |
CY2020Q4 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
1013500 | USD |
CY2021Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
328039 | USD |
CY2020Q4 | gryn |
Shares Issued For Vehicles
SharesIssuedForVehicles
|
188700 | USD |
CY2020Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
765138 | USD |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-472665 | USD |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
40374 | USD |
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
507512 | USD |
CY2020Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
40538 | USD |
CY2021Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
34847 | USD |
CY2020Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
80912 | USD |
CY2021Q4 | us-gaap |
Interest Paid Net
InterestPaidNet
|
207328 | USD |
CY2020Q4 | us-gaap |
Interest Paid Net
InterestPaidNet
|
230036 | USD |
CY2021Q4 | gryn |
Shares Issued For Vehicles
SharesIssuedForVehicles
|
0 | USD |
CY2020Q4 | gryn |
Shares Issued For Prepaid Expenses
SharesIssuedForPrepaidExpenses
|
155383 | USD |
CY2021Q4 | gryn |
Shares Issued For Stock Payable
SharesIssuedForStockPayable
|
712000 | USD |
CY2020Q4 | gryn |
Shares Issued For Stock Payable
SharesIssuedForStockPayable
|
92000 | USD |
CY2021Q4 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p> | |
CY2021Q4 | gryn |
Harvested Flower
harvestedFlower
|
30000 | GBP |
CY2021Q4 | gryn |
Biomass
Biomass
|
40000 | GBP |
CY2020Q4 | gryn |
Cost And Expenses
CostAndExpenses
|
175956 | USD |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
44482138 | shares |
CY2020Q3 | us-gaap |
Deferred Revenue
DeferredRevenue
|
15973 | USD |
CY2021 | gryn |
Production Equipments
ProductionEquipments
|
854899 | USD |
CY2021Q4 | gryn |
Production Equipments
ProductionEquipments
|
836785 | USD |
CY2021 | gryn |
Furniture And Office Equipment
FurnitureAndOfficeEquipment
|
4859 | USD |
CY2021Q4 | gryn |
Furniture And Office Equipment
FurnitureAndOfficeEquipment
|
4451 | USD |
CY2021 | gryn |
Payments To Acquire Building
PaymentsToAcquireBuilding
|
450206 | USD |
CY2021Q4 | gryn |
Payments To Acquire Building
PaymentsToAcquireBuilding
|
442023 | USD |
CY2021 | gryn |
Land And Buildings
LandAndBuildings
|
4212362 | USD |
CY2021Q4 | gryn |
Land And Buildings
LandAndBuildings
|
4212362 | USD |
CY2021 | gryn |
Purchase Of Fixed Assets
PurchaseOfFixedAssets
|
5522326 | USD |
CY2021Q4 | gryn |
Purchase Of Fixed Assets
PurchaseOfFixedAssets
|
5494912 | USD |
CY2021Q4 | us-gaap |
Depreciation
Depreciation
|
62439 | USD |
CY2020Q4 | us-gaap |
Depreciation
Depreciation
|
30177 | USD |
CY2021Q4 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
100078 | USD |
CY2021Q1 | us-gaap |
Notes Issued1
NotesIssued1
|
406137 | USD |
CY2021Q1 | us-gaap |
Short Term Debt Percentage Bearing Fixed Interest Rate
ShortTermDebtPercentageBearingFixedInterestRate
|
0.0475 | pure |
CY2021Q4 | gryn |
Promissory Note Interest Expense
PromissoryNoteInterestExpense
|
4863 | USD |
CY2020Q3 | gryn |
Principal Amount
PrincipalAmount
|
200000 | USD |
CY2021Q4 | gryn |
Imputed Interestandloans
ImputedInterestandloans
|
80275 | USD |
CY2020Q4 | gryn |
Imputed Interestandloans
ImputedInterestandloans
|
76778 | USD |
CY2021Q4 | us-gaap |
Management Fee Expense
ManagementFeeExpense
|
180097 | USD |
CY2020Q4 | us-gaap |
Management Fee Expense
ManagementFeeExpense
|
52500 | USD |
CY2021Q4 | gryn |
Payment Of Related Party Expenses Beginning
PaymentOfRelatedPartyExpensesBeginning
|
523791 | USD |
CY2021Q4 | gryn |
Additions
Additions
|
180097 | USD |
CY2021Q4 | gryn |
Payments
Payments
|
55250 | USD |
CY2021Q4 | gryn |
Payment Of Related Party Expenses Ending
PaymentOfRelatedPartyExpensesEnding
|
648638 | USD |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
375000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021 | us-gaap |
Dividends Share Based Compensation
DividendsShareBasedCompensation
|
355550 | USD |
CY2020Q4 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
100000 | shares |
CY2021 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
50000 | shares |
CY2020Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
50000 | shares |
CY2021 | us-gaap |
Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
|
712000 | USD |
CY2021Q3 | gryn |
Exercise Price Per Warranty
ExercisePricePerWarranty
|
3.00 | |
CY2021 | gryn |
Purchase Shares Of Common Stock
PurchaseSharesOfCommonStock
|
356000 | shares |
CY2021Q4 | gryn |
Summary Of Warrent Activitytabletextblock
SummaryOfWarrentActivitytabletextblock
|
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>Number of </strong></p><p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>Warrants</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>Weighted average exercise price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Outstanding beginning of year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">356,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.00</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Outstanding and exercisable, end of year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">356,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3.00</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> | |
CY2021 | gryn |
Weighted Average Exercise Price Outstanding Beginning Of Year
WeightedAverageExercisePriceOutstandingBeginningOfYear
|
0 | |
CY2021 | gryn |
Number Of Warrants Granted
NumberOfWarrantsGranted
|
356000 | shares |
CY2021 | gryn |
Weighted Average Exercise Price Granted
WeightedAverageExercisePriceGranted
|
3.00 | |
CY2021 | gryn |
Number Of Warrants Outstanding And Exercisable End Of Year
NumberOfWarrantsOutstandingAndExercisableEndOfYear
|
356000 | shares |
CY2021 | gryn |
Weighted Average Exercise Price Outstanding And Exercisable End Of Year
WeightedAverageExercisePriceOutstandingAndExercisableEndOfYear
|
3.00 | |
CY2021Q4 | gryn |
Gain On Forgiveness Of Payabletextblock
GainOnForgivenessOfPayabletextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>11. Gain on Forgiveness of payable</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong> </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three months ended October 31,2021, the company recognized a gain of $180,000 related to a forgiveness of payables from a company that was contracted to perform consulting services related to the accounting and preparation of the company’s quarterly financials. The company received written from the consultant notifying the company of the forgiveness.</p> | |
CY2021Q4 | gryn |
Gain On Forgiveness Of Payable
GainOnForgivenessOfPayable
|
180000 | USD |